SCHEMBL9814285

SCHEMBL9814285

C#CC(Br)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27886141 0.75
SCHEMBL10441951 0.71
SCHEMBL239357 0.67
SCHEMBL20271634 0.67
SCHEMBL7524674 0.67
SCHEMBL709674 0.67
SCHEMBL7513957 0.67
SCHEMBL4473440 0.67
SCHEMBL22802544 0.67
SCHEMBL8528087 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114890993-B Chalcone phenazine hybrid molecule and application thereof 中国药科大学 2023-03-31 CN disclosed
CN-110300589-B Bicyclic heteroaryl derivatives as CFTR potentiators 囊性纤维化基金会 2023-03-10 CN disclosed
CN-114890993-A Chalcone phenazine hybrid molecule and application thereof 中国药科大学 2022-08-12 CN disclosed
CN-106794362-B Carbon monoxide-releasing molecules for therapeutic applications and methods of making and using the same 乔治亚州立大学研究基金会股份有限公司 2021-07-06 CN disclosed
EP-3554506-B1 BYCYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUND (US) 2021-04-28 EP disclosed
US-10766904-B2 Bicyclic heteroaryl derivatives as CFTR potentiators CYSTIC FIBROSIS FOUNDATION (US) 2020-09-08 US disclosed
US-20190330219-A1 BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS PFIZER INC. 2019-10-31 US disclosed
EP-3554506-A1 BYCYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS Cystic Fibrosis Foundation Therapeutics, Inc. (US) 2019-10-23 EP disclosed
US-10377762-B2 Bicyclic heteroaryl derivatives as CFTR potentiators CYSTIC FIBROSIS FOUNDATION (US) 2019-08-13 US disclosed
US-10208053-B2 Bicyclic heteroaryl derivatives as CFTR potentiators CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2019-02-19 US disclosed
US-20190016727-A1 BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2019-01-17 US disclosed
US-20190016728-A1 BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2019-01-17 US disclosed
US-10131670-B2 Bicyclic heteroaryl derivatives as CFTR potentiators CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2018-11-20 US disclosed
US-20180170938-A1 BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2018-06-21 US disclosed
WO-2018112149-A1 BYCYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATON THERAPEUTICS INC. (US) 2018-06-21 WO disclosed
CN-105884761-A 6-O-demethylation side cryptaustoline derivative, application thereof, antiviral activity application and anticancer activity 南开大学 2016-08-24 CN disclosed
EP-0262428-B1 HYDANTOIN DERIVATIVES AND HERBICIDES CONTAINING THE DERIVATIVES AS AN ACTIVE INGREDIENT SAGAMI CHEMICAL RESEARCH CENTER (JP) 1991-08-14 EP disclosed
US-4902337-A Herbicidal hydantoin derivatives SAGAMI CHEMICAL RESEARCH (JP) 1990-02-20 US disclosed
CN-87106076-A Hydantoin derivative and be the weedicide of effective ingredient with this derivative 1988-08-31 CN disclosed
EP-0262428-A1 Hydantoin derivatives and herbicides containing the derivatives as an active ingredient SAGAMI CHEMICAL RESEARCH CENTER (JP) 1988-04-06 EP disclosed